– Invests in 100th Portfolio Company, Celebrates 25th Year of Franchise Operation – – Announces Promotion of Lauren Flickinger and Ben Scruggs, Ph.D.,… Read More
Acquisition will Accelerate Global Expansion of Company’s Breakthrough Edison® Histotripsy Platform and Non-Invasive Tumor Therapy MINNEAPOLIS–(BUSINESS WIRE)–… Read More
– Vigil’s shareholders to receive up to $10.00 per share in cash, comprised of $8.00 per share in cash at closing and a non-tradeable contingent… Read More
– A single intravitreal administration of PER-001 improved both visual function and anatomic structure compared to control at 24 weeks – – These data support… Read More
There’s still money to be raised by gene therapy startups with good clinical data. On Wednesday, North Carolina biotech Atsena Therapeutics said it had raised… Read More
Atsena Therapeutics’ $150 million fundraise is a light of hope for the gene therapy field, which has suffered enormously in recent months. Atsena Therapeutics has… Read More
Strong investor syndicate backs clinical-stage Hepatitis B program while advancing pioneering gene-tuning platform DURHAM, N.C. & SEATTLE–(BUSINESS WIRE)–Leading epigenome editing company Tune Therapeutics… Read More
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) patients AER-01-002 is well powered… Read More
Funding to Advance New Histotripsy Applications and Launch Innovative BOOMBOX Master Study HistoSonics Edison® Histotripsy System (Photo: Business Wire)… Read More
Oversubscribed financing led by strategic investor, with participation from new and existing investors MINNEAPOLIS, June 25, 2024 /PRNewswire/ — Endogenex, a clinical-stage medical device company dedicated to… Read More